Added health benefits of Wegovy, Zepbound could attract more men, doctors say. By Bhanvi Satija and Sriparna Roy. June 10, 2024 4:18 PM UTC Updated June 10, 2024 A combination image ...

The Wegovy trial showed that 569 of 8,803 people taking the drug had a heart attack or stroke or died from heart-related causes, or 6.5%. That’s compared with 701 of 8,801 people on a placebo ...

(CNN) — Results from a landmark clinical trial this summer suggested, for the first time, that a medication given for weight loss alone could reduce the risk of heart attack, stroke or heart ...

The Wegovy trial showed that 569 of 8,803 people taking the drug had a heart attack or stroke or died from heart-related causes, or 6.5%. That's compared with 701 of 8,801 people on a placebo, or 8%.

Long-Term Effects of Wegovy: Risks vs. Benefits. This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. The short-term effects of Wegovy include appetite control and weight loss.

(The new study only tested Wegovy, not Zepbound, so it's not clear whether Zepbound would have the same heart benefits.) In this study, participants lost only about 9% of their body weight on ...

Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...

PHILADELPHIA, Nov 11 (Reuters) - Novo Nordisk NOVOb.CO on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more than weight loss alone ...

Semaglutide -- the active ingredient in the blockbuster weight-loss drugs Ozempic and Wegovy -- can produce long-term weight and heart health benefits, a pair of new studies show.

What to Eat on Wegovy. Eating nutrient-rich foods can maximize the benefits of Wegovy, help reduce side effects, and support a weight loss journey.Here's a breakdown of the key foods that should ...

Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, a new clinical trial shows. Both men and women showed improved heart function after a year on semaglutide, the active ...